BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22742971)

  • 1. Meningococcal meningoencephalitis after certolizumab pegol treatment in a patient with Crohn's disease.
    Majumder S; Kumar A
    J Crohns Colitis; 2013 Feb; 7(1):e19. PubMed ID: 22742971
    [No Abstract]   [Full Text] [Related]  

  • 2. [Certolizumab pegol--new possibilities in the treatment of Crohn's disease].
    Lazebnik LB; Kniazev OV
    Eksp Klin Gastroenterol; 2012; (3):100-5. PubMed ID: 22830233
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-induced erythema nodosum after the administration of certolizumab in Crohn's disease.
    Biedermann L; Kerl K; Rogler G; Hofbauer GF
    Inflamm Bowel Dis; 2013 Jan; 19(1):E4-6. PubMed ID: 22127817
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral lichen planus after certolizumab pegol treatment in a patient with Crohn's disease.
    Mocciaro F; Orlando A; Renna S; Rizzuto MR; Cottone M
    J Crohns Colitis; 2011 Apr; 5(2):173-4. PubMed ID: 21453892
    [No Abstract]   [Full Text] [Related]  

  • 5. Certolizumab pegol: new drug. As a last resort in Crohn's disease: continue to use other TNF alpha inhibitors.
    Prescrire Int; 2009 Jun; 18(101):108-10. PubMed ID: 19637418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance therapy with certolizumab pegol for Crohn's disease.
    Schreiber S; Khaliq-Kareemi M; Lawrance IC; Thomsen OØ; Hanauer SB; McColm J; Bloomfield R; Sandborn WJ;
    N Engl J Med; 2007 Jul; 357(3):239-50. PubMed ID: 17634459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and efficacy of certolizumab pegol in the treatment of Crohn's disease: 7-year results from the PRECiSE 3 study.
    Sandborn WJ; Lee SD; Randall C; Gutierrez A; Schwartz DA; Ambarkhane S; Kayhan C; Pierre-Louis B; Schreiber S; Lichtenstein GR
    Aliment Pharmacol Ther; 2014 Oct; 40(8):903-16. PubMed ID: 25146586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Certolizumab pegol for the treatment of Crohn's disease.
    Sandborn WJ; Feagan BG; Stoinov S; Honiball PJ; Rutgeerts P; Mason D; Bloomfield R; Schreiber S;
    N Engl J Med; 2007 Jul; 357(3):228-38. PubMed ID: 17634458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The classics in perspective.
    Panés J; Ghosh S
    Gut; 2007 Sep; 56(9):1184-6. PubMed ID: 17698863
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug safety evaluation of certolizumab pegol.
    Ferrante M; Vermeire S; Rutgeerts PJ
    Expert Opin Drug Saf; 2014 Feb; 13(2):255-66. PubMed ID: 24156537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: long-term safety and efficacy of certolizumab pegol for Crohn's disease.
    Cesarini M; Danese S
    Aliment Pharmacol Ther; 2014 Nov; 40(10):1243. PubMed ID: 25303376
    [No Abstract]   [Full Text] [Related]  

  • 12. Psoriatic skin lesions induced by certolizumab pegol.
    Klein RQ; Spivack J; Choate KA
    Arch Dermatol; 2010 Sep; 146(9):1055-6. PubMed ID: 20855720
    [No Abstract]   [Full Text] [Related]  

  • 13. Certolizumab pegol for the management of Crohn's disease in adults.
    Rivkin A
    Clin Ther; 2009 Jun; 31(6):1158-76. PubMed ID: 19695385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring, mucosal healing, deep remission: the path to nirvana in Crohn's disease?
    Moss AC
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):432-3. PubMed ID: 24370555
    [No Abstract]   [Full Text] [Related]  

  • 15. Certolizumab pegol (Cimzia) and ustekinumab (Stelara) for psoriatic arthritis.
    Med Lett Drugs Ther; 2014 Feb; 56(1435):10-2. PubMed ID: 24662976
    [No Abstract]   [Full Text] [Related]  

  • 16. Health outcomes and cost-effectiveness of certolizumab pegol in the treatment of Crohn's disease.
    Augustine JM; Lee JK; Armstrong EP
    Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):599-609. PubMed ID: 25209304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Certolizumab (Cimzia) for Crohn's disease.
    Med Lett Drugs Ther; 2008 Oct; 50(1297):81-2. PubMed ID: 18927521
    [No Abstract]   [Full Text] [Related]  

  • 18. Certolizumab pegol: in Crohn's disease.
    Blick SK; Curran MP
    BioDrugs; 2007; 21(3):195-201; discussion 202-3. PubMed ID: 17516714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Certolizumab pegol in Crohn's disease.
    Patel VK; Ghosh S
    Drugs Today (Barc); 2008 Nov; 44(11):837-44. PubMed ID: 19180261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Certolizumab pegol].
    Delgado Frías E; Díaz González JF
    Reumatol Clin; 2011 Mar; 6S3():S7-11. PubMed ID: 21794764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.